Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingliang Fang

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Cancer Biology & Therapy|January 6, 2007
Targeting apoptosis to cancer via hTERT promoterBingliang Fang
Journal of Cancer Metastasis and Treatment|November 15, 2021
Introduction to this Special Issue: "Biomarker Discovery and Precision Medicine"Bingliang Fang
Acta Biochimica Et Biophysica Sinica|September 10, 2015
RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studiesBingliang Fang
Cancers|March 26, 2014
Genetic Interactions of STAT3 and Anticancer Drug DevelopmentBingliang Fang
Journal of Medicinal Chemistry|June 4, 2014
Development of synthetic lethality anticancer therapeuticsBingliang Fang
Cancer Biology & Therapy|September 26, 2003
Telomerase promoter-driven cancer gene therapyJian Gu, Bingliang Fang
Cancer Biology & Therapy|January 8, 2009
Potentiation of oncolytic virotherapy with armed shRNAWei Guo, Bingliang Fang
Cancer Biology & Therapy|March 19, 2008
Enhancing anti-cancer virotherapy with heat-shock protein-mediated immune responseWei Guo, Bingliang Fang
Journal of Thoracic Disease|November 22, 2016
Harnessing plasma genotyping for precision therapy against lung cancerXiang Yan, Bingliang Fang
Cancer Biology & Therapy|January 6, 2007
Dominant Negative RAS as an anticancer agentWei Guo, Bingliang Fang
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Cancer Biology & Therapy|January 6, 2007
Targeting apoptosis to cancer via hTERT promoterBingliang Fang
Journal of Cancer Metastasis and Treatment|November 15, 2021
Introduction to this Special Issue: "Biomarker Discovery and Precision Medicine"Bingliang Fang
Acta Biochimica Et Biophysica Sinica|September 10, 2015
RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studiesBingliang Fang
Cancers|March 26, 2014
Genetic Interactions of STAT3 and Anticancer Drug DevelopmentBingliang Fang
Journal of Medicinal Chemistry|June 4, 2014
Development of synthetic lethality anticancer therapeuticsBingliang Fang
Cancer Biology & Therapy|September 26, 2003
Telomerase promoter-driven cancer gene therapyJian Gu, Bingliang Fang
Cancer Biology & Therapy|January 8, 2009
Potentiation of oncolytic virotherapy with armed shRNAWei Guo, Bingliang Fang
Cancer Biology & Therapy|March 19, 2008
Enhancing anti-cancer virotherapy with heat-shock protein-mediated immune responseWei Guo, Bingliang Fang
Journal of Thoracic Disease|November 22, 2016
Harnessing plasma genotyping for precision therapy against lung cancerXiang Yan, Bingliang Fang
Cancer Biology & Therapy|January 6, 2007
Dominant Negative RAS as an anticancer agentWei Guo, Bingliang Fang
Pageof 17